Lemsip Max Flu Lemon

Pseudoephedrine Hydrochloride, the active ingredient in Lemsip Max Flu Lemon, is a decongestant presented as an oral formulation for oral use. It relieves nasal congestion, fever, headache and body aches associated with colds and flu in adults and children when appropriate. GNH USA supplies Lemsip Max Flu Lemon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lemsip Max Flu Lemon combines pseudoephedrine hydrochloride and paracetamol to relieve cold and flu symptoms.

- Nasal congestion: reduces swelling of nasal passages to improve breathing. - Headache: alleviates pain associated with sinus pressure. - Fever: lowers elevated body temperature. - Body aches: eases muscular discomfort. - Cold symptoms: provides overall relief of typical cold discomfort.

Common Side Effects: - Nausea: mild stomach upset. - Headache: transient head pain. - Insomnia: difficulty sleeping. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation. - Increased heart rate: mild tachycardia.

Serious or Rare Side Effects: - High blood pressure: significant elevation requiring medical attention. - Arrhythmia: irregular heart rhythm. - Severe allergic reaction: rash, swelling, or breathing difficulty. - Liver injury: abnormal liver function tests. - Seizures: rare neurologic events. - Blood disorders: unexplained bruising or bleeding.

Before using Lemsip Max Flu Lemon, consider the following precautions. - Do not exceed the recommended dose: follow prescriber or label instructions. - Avoid use in uncontrolled hypertension: may raise blood pressure. - Consult a physician if taking MAO‑inhibitors or other sympathomimetics. - Use with caution in liver disease: paracetamol metabolism may be impaired. - Pregnant or breastfeeding women should seek medical advice before use. - Store at room temperature: keep in the original pack, protect from moisture.

Lemsip Max Flu Lemon may interact with several medicines.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other decongestants: additive cardiovascular stimulation. - Additional paracetamol‑containing products: risk of overdose and liver toxicity.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Anticoagulants (e.g., warfarin): may enhance bleeding risk. - Alcohol: increased liver strain and sedation.